Page last updated: 2024-08-24

nelfinavir and Leukemia, Myeloid, Acute

nelfinavir has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bader, J; Driessen, C; Kraus, M; Müller-Ide, H; Overkleeft, H; Rückrich, T1

Other Studies

1 other study(ies) available for nelfinavir and Leukemia, Myeloid, Acute

ArticleYear
Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
    Leukemia research, 2014, Volume: 38, Issue:3

    Topics: Apoptosis; Cytotoxins; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Leukemic; HIV Protease Inhibitors; Humans; Leukemia, Myeloid, Acute; Lopinavir; Nelfinavir; Phosphorylation; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Proto-Oncogene Proteins c-akt; Ritonavir; Saquinavir; Signal Transduction; Tumor Cells, Cultured

2014